MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1007/s00406-026-02329-4

Медицинская библиотека · European archives of psychiatry and clinical neuroscience · 2026

Sleep quality partially mediates the association between remnant cholesterol inflammatory index and depressive symptoms: multi-cohort analysis from cross-sectional and longitudinal cohorts.

Liu Pu-Le, Gao Shuo, Chen Xing-Ran, Chai Li-Ying, Yang Ru-Yang, Kong Yan, Jiang Chang-Lian, Li Xiao-E, Zhang Yan, Dong Qiang-Li

СтатьяПеревод в очереди

Аннотация

OBJECTIVE

Previous studies have reported a cross-sectional association between the remnant cholesterol inflammatory index (RCII) and depressive symptoms. However, longitudinal evidence remains limited. This study aimed to examine the associations between RCII, depressive symptoms, and sleep quality, and to assess the mediating role of sleep quality and potential sex differences.

METHODS

Using data from three nationally representative cohorts-NHANES (n = 7,359, USA, cross-sectional), CHARLS (n = 4,551, China, longitudinal), and ELSA (n = 4,808, UK, longitudinal). Multivariable regression models were used to evaluate associations of RCII with depressive symptoms and sleep quality. Mediation analyses were conducted to estimate the indirect effect of sleep quality, with stratification by sex.

RESULTS

Higher RCII levels were consistently associated with greater odds of depressive symptoms after multivariable adjustment in NHANES (OR = 1.16, 95% CI: 1.09-1.24), CHARLS (OR = 1.11, 95% CI: 1.04-1.18), and ELSA (OR = 1.12, 95% CI: 1.03-1.21). Elevated RCII was also significantly associated with poorer sleep quality in NHANES (β = 0.05, P < 0.001), CHARLS (β = 0.02, P = 0.049), and ELSA (β = 0.03, P < 0.001). Poorer sleep quality was, in turn, associated with higher odds of depressive symptoms across all cohorts. Mediation analyses demonstrated significant indirect effects of sleep quality on the association between RCII and depressive symptoms, with adjusted ACMEs of 0.0044 (95% CI: 0.0024-0.0067; P < 0.001), 0.0003 (95% CI: 0.0001-0.0008; P = 0.044), and 0.0005 (95% CI: 0.0004-0.0010; P < 0.001) in NHANES, CHARLS, and ELSA, respectively. Significant direct effects also remained after adjustment, with ADEs of 0.0080 (95% CI: 0.0032-0.0132; P = 0.002), 0.0114 (95% CI: 0.0051-0.0176; P < 0.001), and 0.0076 (95% CI: 0.0004-0.0137; P = 0.036), respectively. The corresponding proportions mediated were 35.41% (95% CI: 20.03%-59.79%), 3.30% (95% CI: 0.17%-10.68%), and 6.17% (95% CI: 5.13%-17.08%), respectively.

CONCLUSIONS

This multinational study provides evidence linking metabolic inflammation, as reflected by RCII, with both depressive symptoms and poor sleep quality. The identification of sleep quality as a partial mediator suggests that sleep disturbance may represent a potential pathway underlying the association between metabolic dysregulation and depression. These findings suggest that RCII may help identify individuals at elevated risk of depressive symptoms, underscoring the importance of integrated strategies targeting metabolic health and sleep in the prevention and management of depressive symptoms.

Для цитирования: Liu Pu-Le, Gao Shuo, Chen Xing-Ran, Chai Li-Ying, Yang Ru-Yang, Kong Yan, Jiang Chang-Lian, Li Xiao-E, Zhang Yan, Dong Qiang-Li. Sleep quality partially mediates the association between remnant cholesterol inflammatory index and depressive symptoms: multi-cohort analysis from cross-sectional and longitudinal cohorts.. European archives of psychiatry and clinical neuroscience. 2026. DOI: 10.1007/s00406-026-02329-4.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.